• Explore /
  • Poster
  • / Safety and activity of nivolumab monotherapy in advanced and metastatic (A/M) gastric or gastroesophageal junction cancer (GC/GEC): Results from the CheckMate-032 study.

Safety and activity of nivolumab monotherapy in advanced and metastatic (A/M) gastric or gastroesophageal junction cancer (GC/GEC): Results from the CheckMate-032 study.

Abstract Poster

Authors

Dung Le

Dung T. Le

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

Dung T. Le , Johanna C. Bendell , Emiliano Calvo , Joseph W. Kim , Paolo Antonio Ascierto , Padmanee Sharma , Patrick Alexander Ott , Petri Bono , Dirk Jaeger , T.R. Jeffry Evans , Filippo G. De Braud , Ian Chau , Olaf Christensen , Christopher Harbison , Chen-Sheng Lin , Yelena Yuriy Janjigian

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Translational Research

Clinical Trial Registration Number

NCT01928394

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 6)

DOI

10.1200/jco.2016.34.4_suppl.6

Abstract #

6

Poster Bd #

F6

Abstract Disclosures

Similar Posters

First Author: Lin Shen

First Author: Ilya Tsimafeyeu

First Author: Lin Shen

First Author: Salah-Eddin Al-Batran